Financhill
Back

Cabaletta Bio Quote, Financials, Valuation and Earnings

Cabaletta Bio Price Quote

$2.39
+0.01 (+3.46%)
(Updated: December 21, 2024 at 5:18 AM ET)

Cabaletta Bio Key Stats

Sell
17
Cabaletta Bio (CABA) is a Sell

Day range:
$2.23 - $2.51
52-week range:
$1.76 - $26.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.67%

Volume:
1.8M
Avg. volume:
3.9M
1-year change:
-88.81%
Market cap:
$116.3M
Revenue:
$0
EPS:
$-2.16

How Much Does Cabaletta Bio Make?

Data Unavailable

Is Cabaletta Bio Growing As A Company?

Data Unavailable

Cabaletta Bio Stock Price Performance

  • Did Cabaletta Bio Stock Go Up Last Month?
    Cabaletta Bio share price went up by 5.31% last month
  • Did CABA's Share Price Rise Over The Last Year?
    CABA share price fell by -88.81% over the past 1 year

What Is Cabaletta Bio 52-Week High & Low?

Cabaletta Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cabaletta Bio?

Data Unavailable

Is Cabaletta Bio Cash Flow Positive?

Data Unavailable

Cabaletta Bio Return On Invested Capital

Data Unavailable

Cabaletta Bio Earnings Date & Stock Price

  • What Is Cabaletta Bio's Stock Price Today?
    A single share of CABA can be purchased today for 2.38
  • What Is Cabaletta Bio’s Stock Symbol?
    Cabaletta Bio trades on the nasdaq under the ticker symbol: CABA
  • When Is Cabaletta Bio’s Next Earnings Date?
    The next quarterly earnings date for Cabaletta Bio is scheduled on March 21, 2025
  • When Is CABA's next ex-dividend date?
    Cabaletta Bio's next ex-dividend date is December 22, 2024
  • How To Buy Cabaletta Bio Stock?
    You can buy Cabaletta Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cabaletta Bio Competitors

  • Who Are Cabaletta Bio's Competitors?
    Below is a list of companies who compete with Cabaletta Bio or are related in some way:
    • Bristol-Myers Squibb Co (BMY)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Cabaletta Bio Dividend Yield

Data Unavailable

Cabaletta Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2.17%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 21.50
Upside from Last Price: 803.36%

Major Shareholders

Data Unavailable